164 related articles for article (PubMed ID: 10985611)
1. Recurrent pregnancy losses and the role of immunotherapy.
Omwandho CA; Tinneberg HR; Tumbo-Oeri AG; Roberts TK; Falconer J
Arch Gynecol Obstet; 2000 Jul; 264(1):3-12. PubMed ID: 10985611
[TBL] [Abstract][Full Text] [Related]
2. Intravenous immunoglobulin (IVIG): modes of action in the clinical management of recurrent pregnancy loss (RPL) and selected autoimmune disorders.
Omwandho CO; Gruessner SE; Roberts TK; Tinneberg HR
Clin Chem Lab Med; 2004 Apr; 42(4):359-70. PubMed ID: 15147144
[TBL] [Abstract][Full Text] [Related]
3. Immunotherapy with intravenous immunoglobulin for treatment of recurrent pregnancy loss: American experience.
Coulam CB
Am J Reprod Immunol; 1994 Dec; 32(4):286-9. PubMed ID: 7718095
[TBL] [Abstract][Full Text] [Related]
4. Intravenous immunoglobulin for treatment of recurrent pregnancy loss.
Coulam CB; Krysa L; Stern JJ; Bustillo M
Am J Reprod Immunol; 1995 Dec; 34(6):333-7. PubMed ID: 8607936
[TBL] [Abstract][Full Text] [Related]
5. Intravenous immunoglobulin for recurrent unexplained pregnancy loss: a case report.
Barnsfather K; Pietrantoni M
J Reprod Med; 2007 Aug; 52(8):737-40. PubMed ID: 17879838
[TBL] [Abstract][Full Text] [Related]
6. Update on immunotherapy for recurrent pregnancy loss.
Coulam CB; Coulam CH
Am J Reprod Immunol; 1992; 27(3-4):124-7. PubMed ID: 1418403
[TBL] [Abstract][Full Text] [Related]
7. Immunotherapy with intravenous immunoglobulin for prevention of recurrent pregnancy loss: European experience.
Mueller-Eckhardt G
Am J Reprod Immunol; 1994 Dec; 32(4):281-5. PubMed ID: 7718094
[TBL] [Abstract][Full Text] [Related]
8. Modulatory effect of intravenous immunoglobulin on Th17/Treg cell balance in women with unexplained recurrent spontaneous abortion.
Muyayalo KP; Li ZH; Mor G; Liao AH
Am J Reprod Immunol; 2018 Oct; 80(4):e13018. PubMed ID: 29984444
[TBL] [Abstract][Full Text] [Related]
9. [Recurrent spontaneous abortion of alloimmunologic etiology--diagnosis and immunotherapy].
Malinowski A
Ginekol Pol; 2001 Nov; 72(11):885-98. PubMed ID: 11848031
[TBL] [Abstract][Full Text] [Related]
10. Immunotherapy for recurrent pregnancy loss: analysis of results from clinical trials.
Coulam CB; Stephenson M; Stern JJ; Clark DA
Am J Reprod Immunol; 1996 Apr; 35(4):352-9. PubMed ID: 8739453
[TBL] [Abstract][Full Text] [Related]
11. Intravenous immune globulin in recurrent abortion.
Heine O; Mueller-Eckhardt G
Clin Exp Immunol; 1994 Jul; 97 Suppl 1(Suppl 1):39-42. PubMed ID: 8033433
[TBL] [Abstract][Full Text] [Related]
12. Alloimmune and autoimmune background in recurrent pregnancy loss - successful immunotherapy by intravenous immunoglobulin.
Kotlan B; Padanyi A; Batorfi J; Fulop V; Szigetvari I; Rajczy K; Penzes M; Gyodi E; Reti M; Petranyi G
Am J Reprod Immunol; 2006 May; 55(5):331-40. PubMed ID: 16635207
[TBL] [Abstract][Full Text] [Related]
13. Blocking antibodies in blood from patients with recurrent spontaneous abortion in relation to pregnancy outcome and intravenous immunoglobulin treatment.
Jablonowska B; Palfi M; Ernerudh J; Kjellberg S; Selbing A
Am J Reprod Immunol; 2001 Apr; 45(4):226-31. PubMed ID: 11327549
[TBL] [Abstract][Full Text] [Related]
14. The influence of intravenous immunoglobulin treatment on maternal immunity in women with unexplained recurrent miscarriage.
Maruyama T; Makino T; Iwasaki K; Sugi T; Saito S; Umeuchi M; Ozawa N; Matsubayashi H; Nozawa S
Am J Reprod Immunol; 1994 Jan; 31(1):7-18. PubMed ID: 8166949
[TBL] [Abstract][Full Text] [Related]
15. Reproductive outcomes 20 years after the intravenous immunoglobulin treatment in women with recurrent pregnancy losses.
Triggianese P; Lattavo G; Chimenti MS; Conigliaro P; Perricone R; Perricone C; De Carolis C
Am J Reprod Immunol; 2020 Apr; 83(4):e13224. PubMed ID: 31971295
[No Abstract] [Full Text] [Related]
16. Intravenous immunoglobulin (IVIG) treatment modulates peripheral blood Th17 and regulatory T cells in recurrent miscarriage patients: Non randomized, open-label clinical trial.
Ahmadi M; Aghdam SA; Nouri M; Babaloo Z; Farzadi L; Ghasemzadeh A; Hamdi K; Movassaghpour AA; Jadidi-Niaragh F; Afkham A; Motallebnezhad M; Eghbal-Fard S; Dolati S; Younesi V; Yousefi M
Immunol Lett; 2017 Dec; 192():12-19. PubMed ID: 29030251
[TBL] [Abstract][Full Text] [Related]
17. Intravenous immunoglobulin therapy for recurrent spontaneous abortion: a meta-analysis.
Daya S; Gunby J; Clark DA
Am J Reprod Immunol; 1998 Feb; 39(2):69-76. PubMed ID: 9506204
[TBL] [Abstract][Full Text] [Related]
18. Does immunotherapy for treatment of reproductive failure enhance live births?
Coulam CB; Acacio B
Am J Reprod Immunol; 2012 Apr; 67(4):296-304. PubMed ID: 22340745
[TBL] [Abstract][Full Text] [Related]
19. The optimal timing of immunotherapy may improve pregnancy outcome in women with unexplained recurrent pregnancy loss: A perspective follow-up study in northeastern China.
Hou Y; Li J; Liu Q; Zhang L; Chen B; Li Y; Bian Y; Huang L; Qiao C
Am J Reprod Immunol; 2020 Apr; 83(4):e13225. PubMed ID: 31985860
[TBL] [Abstract][Full Text] [Related]
20. [The management of unexplained recurrent abortions. Is immunotherapy an option?].
Constantinescu D; Cozmei C; Dumitraşcu I; Carasevici E
Rev Med Chir Soc Med Nat Iasi; 2008; 112(2):371-8. PubMed ID: 19295006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
